Tilray Sees Haywood Slash Price Target To $12.50

On October 7, Tilray Inc (TSX: TLRY) reported their first quarter financial results for the period ending August 31, 2021. The company reported revenues of $168.02 million for the first quarter, up 43% year over year.

Gross profits for the quarter came in at $50.9 million, up 46% year over year, but general and administrative costs grew 91% over the same period to $49.5 million. Cannabis revenue dropped from 44% of the total revenue to 42% of the total revenue, equaling $70.45 million. As expected, the company reported a net loss for the quarter of $34.6 million or earnings per share of negative $0.08.

A number of analysts lowered their 12-month price target on Tilray after the results, bringing the average 12-month price target to $14.25, down from $17.45 prior to the results. Tilray currently has 20 analysts covering the stock with 2 analysts having strong buy ratings, 3 have buys, 13 analysts have holds and 2 have sells on the stock. The street high sits at $27 while the lowest comes in at $1.27.

Haywood Capital Markets was one of the firms to lower their 12-month price target, dropping it to $12.50 from $13.50, while reiterating their hold rating on the company, saying that the quarter generally came in-line “but [they are] taking a cautious look on growth.”

Haywood revised their fiscal 2022 and 2023 estimates lower “to reflect a more conservative top-line growth profile.” They believe that Tilray’s market share of the Canadian adult-use market will grow slower due to increased competition, while the rise of COVID-19 variants “has slowed the global re-opening which has also impacted the cannabis segment but also Tilray’s SweetWater and Wellness operations.”

Below you can see Haywood’s estimates for the quarter. Tilray’s revenue came slightly below their $171.5 million estimate while beating all other estimates, saying that the 18% quarter-over-quarter growth primarily came from a 31% increase in their cannabis segment. They note that with Tilray reporting another quarter of positive adjusted EBITDA, it marks their 10th consecutive quarter. They additionally highlight that management noted that distribution revenue was impacted by roughly $5 million due to facility closures by flooding in Germany.

Below you can see Haywood Capital Markets updated estimates for FY2022 and FY2023.


Information for this briefing was found via Sedar and Refinitiv. The author has no securities or affiliations related to this organization. Not a recommendation to buy or sell. Always do additional research and consult a professional before purchasing a security. The author holds no licenses.

Video Articles

Tariffs Spark New Race for Critical Metals | Rob McEwen

Antimony Resources: The Bald Hill Project

They Laughed at $3,000 Gold, Now We’re Headed for $4,000! | Sean Roosen – Osisko Development Corp.

Recommended

Steadright Begins Preliminary Economic Assessment On TitanBeach Project

Three Miners Trapped Underground At Newmont’s Red Chris Mine

Related News

Organigram: Haywood Raises Estimates Betting On Increased Market Share

On January 11th, Organigram Holdings (TSX: OGI) issued its second fiscal quarter earnings for 2022....

Saturday, January 15, 2022, 11:09:00 AM

MediPharm Labs: Canaccord Resumes Coverage, Issues $2.25 Price Target

As a follow up to the earlier covered resumption of coverage by Canaccord Genuity on...

Monday, July 6, 2020, 04:53:00 PM

Aphria, Tilray Announce $5 Billion Merger Justified By Topline Revenues

Well it appears the rumours have finally come to fruition when it comes to Aphria...

Wednesday, December 16, 2020, 07:39:40 AM

Plug Power: Canaccord Halves Price Target After Q1 Results

On June 22nd, Plug Power (NASDAQ: PLUG) announced their first-quarter results, The company announced net...

Friday, June 25, 2021, 11:42:00 AM

Hive Blockchain: Canaccord Remains Positive On Outlook

On August 26th, Canaccord Genuity Capital Markets’ raised their 12-month price target on Hive Blockchain...

Monday, August 29, 2022, 02:22:00 PM